ArticleScience China. Life sciences2026

ESIRA, a novel framework integrating efficacy and safety for evaluating first-line treatments in advanced hepatocellular carcinoma.

Hai-Long Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.